These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12007158)

  • 21. Prescribing non-psychopharmacological agents: a new potential role for psychologists in primary care settings and specialty clinics.
    Earles JE; James LC; Folen RA
    J Clin Psychol; 2006 Oct; 62(10):1213-20. PubMed ID: 16897696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychologist prescribing: the issues in Maryland.
    Prescott WG
    Md Med; 2002; 3(4):26-8. PubMed ID: 12481744
    [No Abstract]   [Full Text] [Related]  

  • 23. Right to prescribe at issue in proposed "MAC" regulations.
    Ragan CA
    Med Times; 1975 Apr; 103(4):23, 25. PubMed ID: 1117829
    [No Abstract]   [Full Text] [Related]  

  • 24. The 2002 psychologist prescribing law in New Mexico: the psychologists' perspective.
    LeVine ES
    Md Med; 2002; 3(4):24-5, 35. PubMed ID: 12481743
    [No Abstract]   [Full Text] [Related]  

  • 25. Applying our medicine to the psychopharmacology debate.
    Lorion RP
    Am Psychol; 1996 Mar; 51(3):219-24. PubMed ID: 8881530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription privileges for psychologists: opinions of pediatric psychologists and pediatricians.
    Rae WA; Jensen-Doss A; Bowden R; Mendoza M; Banda T
    J Pediatr Psychol; 2008 Mar; 33(2):176-84. PubMed ID: 17884844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug prescribing authority for psychologists: a trend continues.
    Hosp Law Newsl; 2002 Dec; 20(2):6-8. PubMed ID: 12455337
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 29. Integrating clinical psychology into primary care settings.
    James LC
    J Clin Psychol; 2006 Oct; 62(10):1207-12. PubMed ID: 16897698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re: Should psychologists be granted prescription privileges? A review of the prescription privilege debate for psychiatrists.
    Litman LC
    Can J Psychiatry; 2003 Aug; 48(7):496-7; author reply 497. PubMed ID: 12971023
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 2002 psychologist prescribing law in New Mexico: the psychiatrists' perspective.
    Yager J
    Md Med; 2002; 3(4):21-3, 45. PubMed ID: 12481742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importing prescription drugs: risky business.
    Hassel L; Arzuaga P
    Empl Benefits J; 2003 Dec; 28(4):83-6. PubMed ID: 14712740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.
    Birnbaum HG; White AG; Reynolds JL; Greenberg PE; Zhang M; Vallow S; Schein JR; Katz NP
    Clin J Pain; 2006 Oct; 22(8):667-76. PubMed ID: 16988561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rx battle.
    Ortolon K
    Tex Med; 2002 Dec; 98(12):26-8. PubMed ID: 12515243
    [No Abstract]   [Full Text] [Related]  

  • 36. Twenty-first century education: toward greater emphasis on context-social, economic, and educational.
    Peterson RL
    J Clin Psychol; 2005 Sep; 61(9):1121-5. PubMed ID: 15965931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should psychologists have prescribing authority?
    Yates DF; Wiggins JG; Lazarus JA; Scully JH; Riba M
    Psychiatr Serv; 2004 Dec; 55(12):1420-6. PubMed ID: 15572571
    [No Abstract]   [Full Text] [Related]  

  • 38. Modeling costs and burden of informal caregiving for persons with bipolar disorder.
    Wolff N; Perlick DA; Kaczynski R; Calabrese J; Nierenberg A; Miklowitz DJ
    J Ment Health Policy Econ; 2006 Jun; 9(2):99-110. PubMed ID: 17007487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing the costs, benefits, cost-effectiveness, and cost-benefit of psychological assessment: we should, we can, and here's how.
    Yates BT; Taub J
    Psychol Assess; 2003 Dec; 15(4):478-95. PubMed ID: 14692844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.